Death of Lorenzo's Oil creator renews focus on treatment

The death of Augusto Odone, the Italian economist who, with help from a number of AOCS members, developed Lorenzo's Oil to treat his son's fatal adrenoleukodystrophy, has drawn renewed attention to the preventive dietary treatment. A combination of triglycerides from olive and rapeseed oils (glyceryl trioleate and glyceryl trierucate), the oil was shown in a 2005 study to help fight ALD in children who were treated before they began experiencing symptoms of the disease, which is caused by an elevated blood level of very-long-chain saturated fatty acids. It is also credited with prolonging the life of Odone's son, Lorenzo, who died in 2008 at age 30.

View Full Article in:

New York Times (tiered subscription model), The · New York Times (tiered subscription model), The

Published in Brief: